An article in The Economist makes a case for Europe to get up to speed and embrace GMOs. In the 12 years that genetically modified organisms have been commercially available, both profits and areas under cultivation have grown. What the article doesn't fully address are the reasons that Europeans have pretty much refused to jump on the bandwagon.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.